Company / Operating Margin
Anixa Biosciences Inc Operating Margin History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-6586.2%
FY2024
5-year range
-6607.1% / -1284.4%
FY2020-FY2024
Trend
+0.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -6607.1% in FY2023 to -10.2% in FY2016.
Based on SEC 10-K filings.
-6586.2% in FY2024 with a 10-year CAGR of -4550.0%.
Declined from -2565.6% to -6586.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -5301.8pp
- 10-Year Change
- -4550.0pp
Key checks
Key Insights
- In FY2024, operating margin increased 0.3% year-over-year.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -6586.2% | +0.3% |
| FY2023 | -6607.1% | -157.5% |
| FY2022 | -2565.6% | +46.1% |
| FY2020 | -4756.0% | -270.3% |
| FY2019 | -1284.4% | +23.4% |
| FY2018 | -1676.0% | -11.5% |
| FY2017 | -1503.0% | -14620.9% |
| FY2016 | -10.2% | +92.6% |
| FY2015 | -137.5% | +93.2% |
| FY2014 | -2036.2% | -306.2% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026